Tech Company Financing Transactions

Elusys Therapeutics Funding Round

Elusys Therapeutics closed a $5 million financing round on 3/31/2007. Investors included EW Healthcare Partners and INVESCO Private Capital.

Transaction Overview

Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Century Dr. 260
Parsippany, NJ 07054
USA
Email Address
Overview
Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease. For over 10 years, Elusys has been engaged in development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores.
Profile
Elusys Therapeutics LinkedIn Company Profile
Social Media
Elusys Therapeutics Company Twitter Account
Company News
Elusys Therapeutics News
Facebook
Elusys Therapeutics on Facebook
YouTube
Elusys Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elizabeth Posillico
  Elizabeth Posillico LinkedIn Profile  Elizabeth Posillico Twitter Account  Elizabeth Posillico News  Elizabeth Posillico on Facebook
VP - Bus. Development
Jeremy Middleton
  Jeremy Middleton LinkedIn Profile  Jeremy Middleton Twitter Account  Jeremy Middleton News  Jeremy Middleton on Facebook
VP - Finance
Vera Wong
  Vera Wong LinkedIn Profile  Vera Wong Twitter Account  Vera Wong News  Vera Wong on Facebook
VP - Manufacturing
James Porter
  James Porter LinkedIn Profile  James Porter Twitter Account  James Porter News  James Porter on Facebook
VP - Regulatory Affairs
Robin Conrad
  Robin Conrad LinkedIn Profile  Robin Conrad Twitter Account  Robin Conrad News  Robin Conrad on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2007: ANX venture capital transaction
Next: 3/31/2007: DRC Computer venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary